Itamar Medical Ltd. (ITMR): Price and Financial Metrics
GET POWR RATINGS... FREE!
ITMR Stock Price Chart Interactive Chart >
ITMR Price/Volume Stats
|Current price||$30.87||52-week high||$30.91|
|Prev. close||$30.62||52-week low||$16.36|
|Day high||$30.91||Avg. volume||90,796|
|50-day MA||$30.53||Dividend yield||N/A|
|200-day MA||$24.54||Market Cap||497.25M|
Itamar Medical Ltd. (ITMR) Company Bio
Itamar Medical Ltd. engages in the research, development, marketing, sale, and leasing of non-invasive medical devices for the cardiology market. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enables home sleep tests for various sleeping disorders, including obstructive sleep apnea; and Endo PAT device that diagnoses endothelial dysfunction. The company operates in the United States, Canada, Europe, Israel, Japan, the Asia Pacific, and other countries. Itamar Medical Ltd. has a collaboration agreement with SoClean Inc. to offer WatchPAT ONE home sleep apnea test and digital health services through direct-to-consumer channels. The company was formerly known as Itamar Medical (CM) 1997 Ltd. and changed its name to Itamar Medical Ltd. in July 2000. Itamar Medical Ltd. was founded in 1997 and is headquartered in Caesarea, Israel.
Most Popular Stories View All
ITMR Latest News Stream
|Loading, please wait...|
ITMR Latest Social Stream
View Full ITMR Social Stream
Latest ITMR News From Around the Web
Below are the latest news stories about Itamar Medical Ltd that investors may wish to consider to help them evaluate ITMR as an investment opportunity.
Phoenix Holdings Ltd. lowered its position in shares of Itamar Medical Ltd. (NASDAQ:ITMR) by 64.9% in the third quarter, HoldingsChannel reports. The fund owned 124,529 shares of the company’s stock after selling 230,625 shares during the period. Phoenix Holdings Ltd.’s holdings in Itamar Medical were worth $3,762,000 at the end of the most recent quarter. […]
Shares of Itamar Medical Ltd. (NASDAQ:ITMR) have earned a consensus rating of Hold from the seven brokerages that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating on the company. The average 12-month 
External Remote Patient Monitoring Devices (Healthcare IT) Market Worth Observing Growth | Inspire Living, Itamar Medical, JointMetrix Medical
A new research document is added in HTF MI database of 135 pages, titled as ''External Remote Patient Monitoring Devices (Healthcare IT) - Medical Devices Pipeline Product Landscape, 2021'' with detailed analysis, Competitive landscape, forecast and strategies. Latest analysis
Itamar Medical (NASDAQ:ITMR) was downgraded by Zacks Investment Research from a hold rating to a sell rating in a research note issued on Friday, Zacks.com reports. According to Zacks, Itamar Medical Ltd is a medical technology company. It focuses on the development, marketing and sales of diagnostic products based on its proprietary PAT(TM) platform technology.  The post Zacks Investment Research Downgrades Itamar Medical (NASDAQ:ITMR) to Sell appeared first on ETF Daily News .
Global Sleep Apnea Devices Market expected to reach $ 7,171.56 million Growth By 2028||Itamar Medical Ltd., Natus Medical Incorporated, CONTEC MEDICAL SYSTEMS CO., LTD, ResMed
The Sleep Apnea Devices report study also includes the key strategic developments of the market, including R&D, new product launch, M&A, agreements, collaboration, partnerships, venture, global and regional growth of the leading competitors performing in the market on a global
ITMR Price Returns